While this may indicate that the use of primaquine in the local population could be safer than initially evaluated, systematic G6PD deficiency testing will be necessary to successfully implement radical cure regimens for Pv and support future malaria elimination efforts [48]. This evidence concerns the gene G6PD and malaria.